Saccharin and cyclamate inhibit binding of epidermal growth factor.

AUTOR(ES)

Lee, L S

RESUMO

The binding of 125I-labeled mouse epidermal growth factor (EGF) to 18 cell lines, including HeLa (human carcinoma), MDCK (dog kidney cells), HTC (rat hepatoma), K22 (rat liver), HF (human foreskin), GM17 (human skin fibroblasts), XP (human xeroderma pigmentosum fibroblasts), and 3T3-L1 (mouse fibroblasts), was inhibited by saccharin and cyclamate. The human cells were more sensitive to inhibition by these sweeteners than mouse or rat cells. EGF at doses far above the physiological levels reversed the inhibition in rodent cells but not in HeLa cells. In HeLa cells, the doses of saccharin and cyclamate needed for 50% inhibition were 3.5 and 9.3 mg/ml, respectively. Glucose, 2-deoxyglucose, sucrose, and xylitol did not inhibit EGF binding. Previous studies have shown that phorbol esters, strongly potent tumor promoters, also inhibit EGF binding to tissue culture cells. To explain the EGF binding inhibition by such greatly dissimilar molecules as phorbol esters, saccharin, and cyclamate, it is suggested that they operate through the activation of a hormone response control unit.

Documentos Relacionados

• Human epidermal growth factor receptor residue covalently cross-linked to epidermal growth factor.
• Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factor.
• Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.
• Cloning and sequence analysis of a cDNA for rat epidermal growth factor.
• Regulated expression of the tyrosine hydroxylase gene by epidermal growth factor.